Screener
NewAmsterdam Pharma Company NAMS Prepaid Expense And Other Assets Current
Prepaid Expense And Other Assets Current at other companies
Other financials
Where this comes from
Reported directly by NewAmsterdam Pharma Company in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: NewAmsterdam Pharma Company’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333824
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | 424,151 | 490,002 |
| Prepayments and other receivables | 23,996 | 38,138 |
| Marketable securities, current | 209,703 | 146,239 |
| Restricted cash | 1,357 | 1,321 |
| Total current assets | 659,207 | 675,700 |
| Marketable securities, net of current portion | 44,409 | 92,609 |
Item 1. Financial Statements.
FAQ
- What is NewAmsterdam Pharma Company's prepaid expense and other assets current?
- NewAmsterdam Pharma Company (NAMS) reported prepaid expense and other assets current of $24M in Q2 2026.
- How has NewAmsterdam Pharma Company's prepaid expense and other assets current changed year-over-year?
- NewAmsterdam Pharma Company's prepaid expense and other assets current decreased by 21.8% year-over-year, from $30.69M to $24M.
- What is the long-term trend for NewAmsterdam Pharma Company's prepaid expense and other assets current?
- Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's prepaid expense and other assets current has grown at a 55.0% compound annual growth rate (CAGR), from $10.25M to $38.14M.
- What does prepaid expense and other assets current mean?
- Prepaid Expense And Other Assets Current as reported by NewAmsterdam Pharma Company N.V. Ordinary Shares.
Ask your AI about NewAmsterdam Pharma Company's prepaid expense and other assets current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude